Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1029 of 5804
-
Probiotic may restore vaccine power in Antibiotic-Treated babies
Disease control Recruiting nowThe goal of this clinical trial is to investigate whether administering a probiotic (Infloran®) to infants who received antibiotics in the first 28 days of life can restore or enhance their immune response to routine vaccines. Antibiotic use in the first weeks of life can lower …
Phase: PHASE2 • Sponsor: South Australian Health and Medical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New 15-Minute test could stop superbug outbreaks in hospitals
Diagnosis Recruiting now"Candida auris is an emerging fungus that can cause severe infections, particularly in hospitalized patients, and is often resistant to multiple antifungal treatments. Rapid and accurate detection of this pathogen is essential to control its spread in healthcare settings. This s…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
AI assistant could sharpen eye injection choices
Diagnosis Not yet recruitingWe developed an artificial intelligence system, called QiLin, which was designed to assist anti-VEGF treatment decisions in retinal diseases. QiLin was trained and validated via over 20,000 optical coherence tomography images from multicenter datasets, demonstrating strong perfor…
Phase: NA • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
New eye drug aims to clear Vision-Damaging material in wet AMD
Disease control Recruiting nowWhose aim is to: Determine the percentage of patients with resolution of subretinal hyperreflective material (SHRM) at week 16. This study is intended to be performed in the ophthalmology departments or ophthalmology clinics of the participating sites, located in Spain. Macula…
Phase: PHASE4 • Sponsor: Biobizkaia Health Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New Triple-Action drug takes on Hard-to-Treat cancers
Disease control Not yet recruitingThis study is an open-label first-in-human phase I clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of HLX3902 in patients with mCRPC and other advanced solid tumours.
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New insulin algorithm aims to simplify diabetes management
Disease control Recruiting nowFeasibility study to evaluate the safety and feasibility of Omnipod automated insulin delivery algorithms in individuals with type 1 diabetes. This study will enroll up to 80 participants to have a minimum of 48 participants to initiate the use of Omnipod. The study will include …
Phase: NA • Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Shorter TB course could be Game-Changer for HIV patients
Disease control Not yet recruitingThis study adopts a multicenter, open-label, randomized controlled design, conducted across key designated AIDS diagnosis and treatment hospitals nationwide. It aims to compare the efficacy and safety of the 2HPMZ/2HPM regimen versus the 2HRZE/4HR regimen in treating HIV-associat…
Phase: NA • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Brain training and new drug combo tested to fight memory loss in stroke risk patients
Disease control Not yet recruitingThis study aims to evaluate whether digital cognitive training and/or intensive lipid-lowering therapy with a PCSK9 inhibitor can improve cognitive function in patients with intracranial atherosclerosis (ICAS). ICAS is a common cause of stroke and is also linked to thinking and …
Phase: PHASE4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Weight-Loss drug may also protect heart arteries
Disease control Not yet recruitingThis multicenter, randomized, double-blind, placebo-controlled trial aims to evaluate the effect of mazdutide, a dual GLP-1/GCG receptor agonist, on coronary plaque progression assessed by coronary computed tomography angiography (CCTA) in patients with coronary atherosclerosis a…
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Watching yourself parent: a video program aims to boost Kids' emotional health
Disease control Recruiting nowThe LOVING study is a randomized controlled trial designed to determine whether adaptations to an internationally recognized parenting program that enhances sensitive caregiving likewise improves sensitive caregiving in Singapore and, in turn, downstream child outcomes in emotion…
Phase: NA • Sponsor: National University of Singapore • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New inhaler powder aims to ease breathing for COPD patients
Disease control Recruiting nowTo evaluate the efficacy and safety of a 12-week administration of HSK39004 inhalation powder in clinical trial participants with COPD
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Could a common probiotic keep precancerous colon polyps away?
Prevention Recruiting nowThe prevention of recurrence after colorectal adenoma resection remains an urgent medical issue to be addressed. Previous studies have mainly focused on nonsteroidal anti-inflammatory drugs, calcium supplements, and vitamins. The gut microbiota and its metabolic products are beli…
Phase: PHASE4 • Sponsor: The Affiliated Hospital of Qingdao University • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Massive study aims to crack the code of KRAS-Mutant pancreatic cancer
Knowledge-focused Recruiting nowConstruction and Maintenance of a Precision Subtyping-Based Clinical Cohort for Targeted Therapy in KRAS-Mutant Pancreatic Cancer
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Can an online program help teens stop Self-Injury?
Symptom relief Recruiting nowThe overall purpose of the study is to implement and evaluate IERITA (Internet-delivered Emotion Regulation Individual Therapy for Adolescents) within child and adolescent mental health services for adolescents engaging in nonsuicidal self-injury (NSSI) and optimize treatment out…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Food as medicine: can cooking classes and grocery delivery lower blood pressure?
Disease control Recruiting nowThe goal of this clinical trial is to treat both hypertension and obesity in adults using a food is medicine framework. Participants will be randomized 1:1 to FIM+DASH or usual-care control. The 24-week trial includes a 12-week FIM+DASH intervention followed by a 12-week maintena…
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
No-Stitch eye gel could heal corneal wounds faster
Disease control Not yet recruitingCorneal blindness is one of the leading causes of blindness worldwide. For various infectious and non-infectious corneal diseases, current clinical repair strategies include corneal lesion debridement, conjunctival flap coverage, amniotic membrane transplantation, corneal transpl…
Phase: NA • Sponsor: Suxia Li • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug combo targets genetic fatty liver in Mid-Stage trial
Disease control Recruiting nowThis study will test a study drug called ALN-PNP with and without another drug that is used for controlling blood sugar, appetite, and weight (for example, tirzepatide), to see if it can help treat MASLD, also known as fatty liver disease. ALN-PNP reduces the amount of Patatin-li…
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
No-Stitch eye glue could spare patients pain and scarring
Disease control Not yet recruitingWhen severe ocular surface lesions occur (e.g., pterygium, corneal ulcer, ocular surface burn, etc.), the currently clinically common surgical procedures such as conjunctival flap coverage, amniotic membrane transplantation, and keratoplasty are primarily fixed by suturing. Howev…
Phase: NA • Sponsor: Suxia Li • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could ecstasy help treat bulimia? early trial begins
Disease control Recruiting nowThis project will evaluate MDMA Assisted Therapy (MDMA-AT) assisted psychotherapy for the treatment of Bulimia Nervosa (BN) over a 10-week period. Preliminary data suggests that MDMA can facilitate heightened openness and reduce anxiety. This study will determine whether MDMA-ass…
Phase: PHASE1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug combo shows promise for tough cancers
Disease control Recruiting nowThe main purpose of the study is to evaluate the safety, tolerability and recommended dose of PM54 in combination with pembrolizumab. To assess the antitumor activity of PM54 in combination with pembrolizumab in terms of clinical benefit rate (CBR) and objective response rate (OR…
Phase: PHASE1, PHASE2 • Sponsor: PharmaMar • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC